This paper together with the other studies, establishing the importance of C1q–gC1qR interaction in disease models, where complement activation is a critical factor in disease progression such as atherosclerosis and Alzheimer’s disease, could be relevant for the development of novel therapeutic strategies. The gene discussed is C1QBP; the disease is early-onset autosomal dominant Alzheimer disease.